I can understand you scepticism, however, given the recent massive bull run from 3c to 10c before a slight pull back before peaking around 13c without any news/announcement with real substance I feel that a lot of it was fuelled by unrealistic expectations and fear of missing out especially in the midst of reporting season.
After having a closer look at the half yearly report, there has been further shareholder dilution resulting from 1,350,000 convertible notes issue in October 2020 being converted into ordinary shares at 3c each, plus 209,000,000 shares to the vendor of HHC (which is in line with previous announcement) and 28,907,048 additional shares issued based on performance (ie exceeding profit guidance).
I personally don't have a problem with additional shares issued based on management exceeding KPIs. I think it gives them an incentive to meet or exceed their KPIs and aligns their interest with us as shareholders. I think it would be prudent to be patient and endure short term pain for long term gain during this correction/pull back.
I think the short term price action will consolidate around 3c - 4c awhile before heading back up north so I plan to accumulate during this correction as it's one of my core holdings. I'd love to know what your view is as long term holder. Best of luck!
- Forums
- ASX - By Stock
- CI1
- Credit Intelligence CI1 - The other side of BNPL (and its profitable)
Credit Intelligence CI1 - The other side of BNPL (and its profitable), page-350
Featured News
Add CI1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.685M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CI1 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online